Mazdutide 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only – not for human or veterinary use.

Product Overview
Mazdutide is a synthetic research peptide designed for the study of metabolic and endocrine signalling pathways involving glucagon-like peptide-1 (GLP-1) and glucagon receptor activity. This 10 mg lyophilized preparation is intended for controlled laboratory research focused on dual-receptor signalling dynamics, energy regulation and metabolic pathway modelling.

Peptide Overview
Mazdutide is classified as a dual GLP-1 and glucagon receptor agonist, structurally engineered to interact with multiple incretin-related pathways. Scientific interest in dual-agonist peptides expanded significantly between 2010 and 2020 as researchers explored combined receptor activation models for metabolic regulation and energy balance studies.

Historical Background and Scientific Context
Research into incretin and glucagon signalling pathways dates back to the late 20th century, with GLP-1 identified as a central regulator of glucose-dependent signalling. From 2010 onward, next-generation dual-agonist peptides such as mazdutide emerged in laboratory research as tools for studying synergistic receptor activation, metabolic flexibility and endocrine signalling complexity.

Between 2015 and 2025, mazdutide has been increasingly utilised in controlled research environments to investigate combined GLP-1 and glucagon receptor dynamics and downstream metabolic response pathways.

Structural & Molecular Characteristics
• Amino-acid chain length: approximately 31 amino acids
• Peptide family: dual incretin receptor agonist analogue
• Structural classification: synthetic modified peptide
• Key design feature: dual GLP-1 and glucagon receptor interaction
• Functional domain: metabolic and endocrine signalling regions

Mechanistic Focus in Research

• Dual GLP-1 and glucagon receptor signalling studies
• Metabolic regulation and energy balance research models
• Endocrine pathway interaction analysis
• Comparative studies of dual-agonist peptide structures
• Controlled in-vitro biochemical experimentation

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Synthetic Mazdutide research peptide
• Purity level exceeds 99 %
• Dual GLP-1 and glucagon receptor agonist analogue
• Designed for metabolic and endocrine signalling research
• Enhanced stability through structural modification
• High analytical consistency and reproducibility
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.